This article considers the challenges and potential benefits of combining the two. The nasal delivery of biologics offers considerable potential for both local and systemic action and for direct access to the brain and CNS to address currently unmet therapeutic need. The unique features of biologics are discussed with reference to the associated difficulties of nasal delivery and the benefits of partnership with experts such as Aptar Pharma is highlighted. Work on the development of vaccines and prophylactics for COVID-19 illustrates what is achievable.
Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery
This Might Also Be of Interest
Aptar Pharma discusses intranasal administration for CNS therapeutics
Webinars, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions
New solutions for pre-clinical discovery in respiratory healthcare
Webinars, Pharmaceutical, Market Insights, Product Solutions, Device Innovations
Improving Intranasal Sprays for Respiratory Viral Infections
Publications, Pharmaceutical, Product Solutions, Device Innovations, Brand Differentiation
The Go-To Drug Delivery Expert
Brochures, Pharmaceutical, Sustainability, Device Innovations, Brand Differentiation, Product Solutions
